CD200R1 deficiency was found to alter the tumor microenvironment (TME), leading to accelerated tumor growth and reduced T cell infiltration and/or effector function, while CD200R1 expression was significantly lower in HNSCC tumors than that in normal tissues. The gene discussed is CD200R1; the disease is neoplasm.